We subsequently formulated a more particular probe, [18F]CFA, which was Utilized in the current review to evaluate dCK action in tumors when addressed with a small molecule dCK inhibitor. This probe can also be being analyzed within a scientific demo at our establishment To guage changes in dCK exercise following cancer immunotherapy eighteen. PET